rheumatoid arthritis Related News
Common workplace fumes may increase rheumatoid arthritis risk
Research suggests that breathing common workplace dust and fumes may heighten rheumatoid arthritis risk.
Rheumatoid arthritis is a long-term condition causing pain, swelling and stiffness...
One in five patients missed out on a rheumatoid arthritis diagnosis during COVID
A new study by Kings College London has found that the number of patients receiving their rheumatoid arthritis diagnosis fell by 20% in the...
New drug could revolutionise rheumatoid arthritis treatment
A new drug for treating rheumatoid arthritis has shown to be highly effective and could offer patients new hope.
Rheumatoid arthritis is a long-term condition...
Decline in incidences of dementia and heart failure in RA patients
The risk of patients with rheumatoid arthritis (RA) developing dementia or heart failure has declined significantly since the 1980s, new research has shown.
Two groups...
Research collaboration to seek rheumatoid arthritis treatments
A new research collaboration and licence agreement between Imcyse and Pfizer will seek to find treatments for rheumatoid arthritis.
Imcyse, a clinical-stage biopharmaceutical company pioneering...
Increased risk of dying for rare autoimmune patients during COVID-19
A new study has shown that people living with rare autoimmune diseases are at heightened risk of dying during COVID-19, a finding that can...
Molecule in lymphatic system implicated in autoimmune diseases
A new study has revealed how a molecule in the lymphatic system could have the potential to play a role in autoimmune diseases.
A study...
Combination therapy for joint rejuvenation and preservation launched
A new combination therapy injection treatment has been launched that could provide a treatment option for people with arthritis and other similar conditions.
The Regenerative...
Arthritis Foundation Releases First CBD Guidance for adults with arthritis
The Arthritis Foundation, in partnership with top experts in arthritis pain and CBD, offers patients a practical, first-of-its-kind resource with answers to their most...
No link discovered between cancer and tumour necrosis factor inhibitor
Including data from over 8,000 people, research suggests that there is no link between cancer and tumour necrosis factor inhibitor (TNFi) use in psoriatic...
Discover the new option for treating rheumatoid arthritis with janus kinase
Ever heard of janus kinase? Well, according to researchers this inhibitor has proven to be a new option for treating rheumatoid arthritis.
In a large-scale,...
Chronic joint inflammation: spondyloarthritis
Researchers have found that unconventional immune cells trigger disturbed cytokine production in the chronic joint inflammation, spondyloarthritis.
Cytokine blockade of Tumor Necrosis Factor (TNF) and...
In focus: rheumatoid arthritis medication and treatments
What do we know about rheumatoid arthritis medication? What are the recommended first-line treatment for this debilitating disease? Read more as Health Europa investigates.
Rheumatoid arthritis...